CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 144 Insider Sale of Securities
- 4 Planned sale 10% owner sold 24,553 shares at an average $6.50 ($159,655)
- 4 Planned sale 10% owner sold 113,099 shares at an average $6.01 ($679,870)
- 4 Planned sale 10% owner sold 298,649 shares at an average $6.07 ($1,812,378)
- 4 Planned sale 10% owner sold 330,210 shares at an average $6.23 ($2,058,247)
- 144 Insider Sale of Securities
- 4 Planned sale 10% owner sold 29,515 shares at an average $6.08 ($179,563)
- 4 Planned sale 10% owner sold 251,360 shares at an average $6.14 ($1,543,899)
- 4 Planned sale 10% owner sold 538,375 shares at an average $5.99 ($3,223,939)
- 4 Planned sale 10% owner sold 524,297 shares at an average $5.57 ($2,922,426)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 22,000 shares at $5.84 ($128,396)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 22,000 shares at $4.99 ($109,811)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Director sold 22,000 shares at $4.99 ($109,699)
- 8-K Event Other events
- 4 Planned sale EVP and Chief Medical Officer sold 10,382 shares at an average $5.47 ($56,791)
- 144 Insider Sale of Securities
Page 7 of 41 · 806 filings